Medication info
Atorvastatin 10 mg Tablet (Atorvastatin Calcium Trihydrate)

Atorvastatin 10 mg Tablet (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200705992 · Notified 2007.05.25 · Insurance code 642100980

Summary

Main use
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia); prevention of cardiovascular diseases (such as myocardial infarction)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg once daily or 40 mg (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). The dose should be adjusted appropriately for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of hyperlipidemia (including pediatric familial hyperlipidemia); prevention of cardiovascular diseases (such as myocardial infarction)

  • Multiple risk factors for coronary artery disease
  • myocardial infarction
  • stroke
  • vascular surgery
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • non-fatal myocardial infarction
  • fatal and non-fatal stroke
  • congestive heart failure
  • angina
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. Specifically, it helps lower the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary artery disease and in patients with type 2 diabetes. Additionally, it reduces the risk of myocardial infarction, stroke, vascular surgery, hospitalization for congestive heart failure, and angina in patients with established coronary artery disease. This medication is also effective in treating hyperlipidemia and is used to decrease bad cholesterol levels and increase good cholesterol levels in patients with primary and mixed dyslipidemia. It is particularly helpful for certain types of hypercholesterolemia and hypertriglyceridemia that do not respond to dietary changes. Furthermore, it is used as an adjunct for lowering cholesterol levels in pediatric patients with familial hypercholesterolemia during growth. Therefore, this medication is widely used for the reduction of cardiovascular disease risk and the treatment of hyperlipidemia.

How to take

Adult dose

Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg once daily or 40 mg (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). The dose should be adjusted appropriately for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may pose a risk of muscle problems; therefore, if symptoms such as muscle pain or weakness occur, discontinue use immediately and consult a doctor. This medication should not be taken if there are certain conditions, or if pregnant or breastfeeding. Patients with poor liver function or those who consume alcohol excessively should periodically check their liver health status when using this medication. This medication may interact with other drugs; therefore, it is essential to inform your doctor or pharmacist about any other medications you are taking. During treatment, regular liver function tests and blood tests should be conducted, and it is crucial to notify healthcare personnel immediately of any abnormal symptoms. Children, the elderly, and patients with reduced kidney function should exercise increased caution when using this medication, and dosage adjustments may be necessary. Women who are pregnant or may become pregnant must use effective contraceptive methods while taking this medication, and the medication should be discontinued upon confirmation of pregnancy. This medication contains lactose; therefore, it should not be taken by patients with lactose intolerance. There is no specific antidote for overdose, so treatment should be based on symptoms, monitoring liver function and muscle condition. This medication should be stored out of the reach of children and kept in its original container for safety.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 146 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vasomotor edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • reduced testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • hypertriglyceridemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hyperplasia
  • hypothermia
  • sleep disorders
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • cognitive impairment
  • muscle weakness
  • ocular muscle weakness
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • pigmenturia
  • vasogenic edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • taste distortion
  • taste loss
  • taste misperception
  • itching
  • rash
  • alopecia
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • sweating
  • urticaria
  • eczema
  • seborrhea
  • skin ulcers
  • cerebral hemorrhage
  • optic nerve degeneration
  • single episode of tetanic seizures
  • central nervous system vascular injury

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. Additionally, it is recommended to keep it at room temperature, away from excessive heat or cold.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.